Research ArticleArticle
Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy
Kalle Jyri Aaltonen, Jaana Tuulikki Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka, Tea Uusitalo, Marja Blom, Yrjö Tapio Konttinen and Dan Nordström
The Journal of Rheumatology March 2015, 42 (3) 372-378; DOI: https://doi.org/10.3899/jrheum.140853
Kalle Jyri Aaltonen
From the University of Helsinki, and the Helsinki University Central Hospital, Helsinki; Jyväskylä Central Hospital, Jyväskylä; Tampere University Hospital, Tampere; Turku University Central Hospital, Turku; South Karelia Central Hospital, Lappeenranta; Kanta-Häme Central Hospital, Hämeenlinna,
Finland.
Jaana Tuulikki Joensuu
Liisa Virkki
Tuulikki Sokka
Pasi Aronen
Heikki Relas
Heikki Valleala
Vappu Rantalaiho
Laura Pirilä
Kari Puolakka
Tea Uusitalo
Marja Blom
Yrjö Tapio Konttinen
REFERENCES
- 1.↵Finnish Medical Society Duodecim and the Finnish Society for Rheumatology. [Rheumatoid arthritis. Current care guideline]. [Article in Finnish] [Internet. Accessed November 25, 2014.] Available from: www.kaypahoito.fi/web/english/guidelines/guideline?id=ccs00063&suositusid=hoi21010
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Raaschou P,
- Simard JF,
- Holmqvist M,
- Askling J;
- ARTIS Study Group
- 6.↵
- Askling J,
- Fored CM,
- Brandt L,
- Baecklund E,
- Bertilsson L,
- Feltelius N,
- et al.
- 7.↵
- Askling J,
- van Vollenhoven RF,
- Granath F,
- Raaschou P,
- Fored CM,
- Baecklund E,
- et al.
- 8.↵
- 9.↵
- 10.↵
- Galloway JB,
- Hyrich KL,
- Mercer LK,
- Dixon WG,
- Fu B,
- Ustianowski AP,
- et al.
- 11.↵
- van Dartel SS,
- Fransen J,
- Kievit W,
- Flendrie M,
- den Broeder AA,
- Visser H,
- et al.
- 12.↵
- Dixon WG,
- Watson K,
- Lunt M,
- Hyrich KL,
- Silman AJ,
- Symmons DP
- 13.↵
- Ramiro S,
- Gaujoux-Viala C,
- Nam JL,
- Smolen JS,
- Buch M,
- Gossec L,
- et al.
- 14.↵
- 15.↵
- van Vollenhoven RF,
- Emery P,
- Bingham CO 3rd,
- Keystone EC,
- Fleischmann RM,
- Furst DE,
- et al.
- 16.↵Finnish Cancer Registry. Institute for Statistical and Epidemiological Cancer Research. [Internet. Accessed November 25, 2014.] Available from: www.cancer.fi/syoparekisteri/en/
- 17.↵National Institute for Health and Welfare. Specialized health care services. [Internet. Accessed November 25, 2014.] Available from: www.thl.fi/en/web/thlfi-en/statistics/statistics-by-topic/specialised-health-care-services
- 18.↵
- Faraway JJ
- 19.↵
- 20.↵
- Singh JA,
- Wells GA,
- Christensen R,
- Tanjong Ghogomu E,
- Maxwell L,
- MacDonald JK,
- et al.
- 21.↵
- Keystone EC
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- Smitten AL,
- Choi HK,
- Hochberg MC,
- Suissa S,
- Simon TA,
- Testa MA,
- et al.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 3
1 Mar 2015
Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy
Kalle Jyri Aaltonen, Jaana Tuulikki Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka, Tea Uusitalo, Marja Blom, Yrjö Tapio Konttinen, Dan Nordström
The Journal of Rheumatology Mar 2015, 42 (3) 372-378; DOI: 10.3899/jrheum.140853
Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy
Kalle Jyri Aaltonen, Jaana Tuulikki Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka, Tea Uusitalo, Marja Blom, Yrjö Tapio Konttinen, Dan Nordström
The Journal of Rheumatology Mar 2015, 42 (3) 372-378; DOI: 10.3899/jrheum.140853